Immunoblot analysis of these pathways confirmed the findings of the phosphoprotein array, suggesting that STAT3 is activated independent of EGFR in these NSCLC cells (Fig. 1C). This evidence concerns the gene STAT3 and non-small cell lung carcinoma.